8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.22%
Positive revenue growth while 2127.T is negative. John Neff might see a notable competitive edge here.
0.43%
Positive gross profit growth while 2127.T is negative. John Neff would see a clear operational edge over the competitor.
3.96%
Positive EBIT growth while 2127.T is negative. John Neff might see a substantial edge in operational management.
4.58%
Positive operating income growth while 2127.T is negative. John Neff might view this as a competitive edge in operations.
3.45%
Positive net income growth while 2127.T is negative. John Neff might see a big relative performance advantage.
3.44%
Positive EPS growth while 2127.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
3.44%
Positive diluted EPS growth while 2127.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 2127.T is at 0.09%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 2127.T is at 0.16%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
4.61%
OCF growth of 4.61% while 2127.T is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
4.61%
FCF growth of 4.61% while 2127.T is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
24.33%
10Y revenue/share CAGR under 50% of 2127.T's 346.77%. Michael Burry would suspect a lasting competitive disadvantage.
44.56%
5Y revenue/share CAGR similar to 2127.T's 48.12%. Walter Schloss might see both companies benefiting from the same mid-term trends.
20.69%
3Y revenue/share CAGR above 1.5x 2127.T's 13.38%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
23.06%
Below 50% of 2127.T's 164.79%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
21.77%
Positive 5Y CAGR while 2127.T is negative. John Neff might view this as a strong mid-term relative advantage.
-8.85%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
138.51%
Below 50% of 2127.T's 530.50%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
97.30%
5Y equity/share CAGR at 50-75% of 2127.T's 137.63%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
46.99%
3Y equity/share CAGR similar to 2127.T's 45.47%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
88.89%
Dividend/share CAGR of 88.89% while 2127.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
No Data
No Data available this quarter, please select a different quarter.
-2.02%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.88%
Inventory is declining while 2127.T stands at 12.08%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.52%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.65%
Positive BV/share change while 2127.T is negative. John Neff sees a clear edge over a competitor losing equity.
73.31%
Debt growth of 73.31% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-0.35%
We cut SG&A while 2127.T invests at 14.62%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.